APC polymorphisms and the risk of colorectal neoplasia: A huge review and meta-analysis

American Journal of Epidemiology

Volumn 177, Issue 11, 2013, Pages 1169-1179

  Liang, Jing ^b   Lin, Chunqing ^b   Hu, Fulan ^b   Wang, Fan ^b   Zhu, Lin ^b   Yao, Xiaoping ^b   Wang, Yibaina ^b   Zhao, Yashuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

APC gene; colorectal cancer; epidemiology; genetics; genome, human; meta analysis; polymorphism

Indexed keywords

APC PROTEIN;

COMPARATIVE STUDY; DATABASE; DISEASE INCIDENCE; DISEASE SEVERITY; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HEALTH RISK; META-ANALYSIS; POLYMORPHISM;

CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL ADENOMA; COLORECTAL CANCER; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; JEW; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; WILD TYPE;

APC GENE; COLORECTAL CANCER; EPIDEMIOLOGY; GENETICS; GENOME, HUMAN; META-ANALYSIS; POLYMORPHISM;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; COLORECTAL NEOPLASMS; GENES, APC; HUMANS; MUTATION, MISSENSE;

ISRAEL; JERUSALEM [ISRAEL];

EID: 84878562585     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws382     Document Type: Review

References (60)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin. 2010;60(5):277-300.
2. Grogan L, Kirsch IR. Genetic testing for cancer risk assessment: a review. Oncologist. 1997;2(4):208-222.
3. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66(3):589-600.
4. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer. 2001;1(1):55-67.
5. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science. 1997;275(5307):1784-1787.
6. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet. 1992;1(4):229-233.
7. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat. 1993;2(6):425-434.
8. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121(2):282-301.
9. Egan JB, Jacobs ET, Martinez ME, et al. Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma. Cancer Res. 2008; 68(14):6006-6013.
10. Chen SP, Tsai ST, Jao SW, et al. Single nucleotide polymorphisms of the APC gene and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer. 2006;6:83.
11. Rozek LS, Rennert G, Gruber SB. APC E1317Q is not associated with colorectal cancer in a population-based casecontrol study in Northern Israel. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2325-2327.
12. Zhou XL, Eriksson U, Werelius B, et al. Definition of candidate low risk APC alleles in a Swedish population. Int J Cancer. 2004;110(4):550-557.
13. Kapitanovic S, Cacev T, Radosevic S, et al. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol. 2004;77(3):193-200.
14. Figer A, Irmin L, Geva R, et al. Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer. 2001;85(4):523-526.
15. Hall MJ, Liberman E, Dulkart O, et al. Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Ann Oncol. 2009;20(9):1517-1521.
16. Bougatef K, Marrakchi R, Ouerhani S, et al. No evidence of the APC D1822V missense variant's pathogenicity in Tunisian patients with sporadic colorectal cancer. Pathol Biol (Paris). 2009;57(3):e67-e71.
17. Theodoratou E, Campbell H, Tenesa A, et al. Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by APC variants. Carcinogenesis. 2008;29(9):1774-1780.
18. Cleary SP, Kim H, Croitoru ME, et al. Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk. Dis Colon Rectum. 2008;51(10): 1467-1473; discussion 73-74.
19. Azzopardi D, Dallosso AR, Eliason K, et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res. 2008; 68(2):358-363.
20. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997;17(1):79-83.
21. Campos FG, LogulloWaitzberg AG, Kiss DR, et al. Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp. 2005;20(1):18-25.
22. Slattery ML, Boucher KM, Caan BJ, et al. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998;148(1):4-16.
23. Turner F, Smith G, Sachse C, et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer. 2004;112(2):259-264.
24. Guerreiro CS, Cravo ML, Brito M, et al. The D1822VAPC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr. 2007;85(6):1592-1597.
25. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and meta-analysis of the association between ? 2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005;162(3):201-211.
26. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56(4):297-303.
27. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120-132.
28. Bax L, Yu LM, Ikeda N, et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50.
29. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-1101.
30. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-634.
31. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics. 2000;56(2):455-463.
32. Tranah GJ, Giovannucci E, Ma J, et al. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14(4): 863-870.
33. Menendez M, Gonzalez S, Blanco I, et al. Colorectal cancer risk and the APC D1822V variant. Int J Cancer. 2004; 112(1):161-163.
34. Slattery ML, SamowitzW, Ballard L, et al. A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res. 2001; 61(3):1000-1004.
35. Wong HL, Peters U, Hayes RB, et al. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer. 2010;46(13): 2457-2466.
36. Picelli S, Zajac P, Zhou XL, et al. Common variants in human CRC genes as low-risk alleles. Eur J Cancer. 2010;46(6): 1041-1048.
37. Fidder HH, Figer A, Geva R, et al. Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am J Gastroenterol. 2005;100(6):1376-1380.
38. Fearnhead NS,Wilding JL, Winney B, et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A. 2004;101(45):15992-15997.
39. Hahnloser D, Petersen GM, Rabe K, et al. The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1023-1028.
40. Gismondi V, Bonelli L, Sciallero S, et al. Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas. Genet Test. 2002;6(4):313-317.
41. Popat S, Stone J, Coleman G, et al. Prevalence of the APC E1317Q variant in colorectal cancer patients. Cancer Lett. 2000;149(1-2):203-206.
42. Lamlum H, Al Tassan N, Jaeger E, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet. 2000;9(15):2215-2221.
43. Dundar M, Caglayan AO, Saatci C, et al. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population. Cancer Genet Cytogenet. 2007;177(2):95-97.
44. Rennert G, Almog R, Tomsho LP, et al. Colorectal polyps in carriers of the APC I1307K polymorphism. Dis Colon Rectum. 2005;48(12):2317-2321.
45. Locker GY, Lynch HT. Genetic factors and colorectal cancer in Ashkenazi Jews. Fam Cancer. 2004;3(3-4): 215-221.
46. Guo J, Lim R, Soo R, et al. APC I1307K and the E1317Q variants are not present in Chinese colorectal cancer patients. Genet Med. 2004;6(4):237-238.
47. Rozen P, Naiman T, Strul H, et al. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect. Cancer. 2002; 94(10):2561-2568.
48. Stern HS, Viertelhausen S, Hunter AG, et al. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews. Gastroenterology. 2001;120(2):392-400.
49. Shtoyerman-Chen R, Friedman E, Figer A, et al. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Genet Test. 2001;5(2): 141-146.
50. Figer A, Shtoyerman-Chen R, Tamir A, et al. Phenotypic characteristics of colorectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer. 2001;85(9):1368-1371.
51. Evertsson S, Lindblom A, Sun XF. APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients. Eur J Cancer. 2001;37(4):499-502.
52. Syngal S, Schrag D, Falchuk M, et al. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000;284(7):857-860.
53. Drucker L, Shpilberg O, Neumann A, et al. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype. Cancer. 2000;88(4):755-760.
54. Prior TW, Chadwick RB, Papp AC, et al. The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology. 1999;116(1):58-63.
55. Gryfe R, Di Nicola N, Lal G, et al. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet. 1999;64(2):378-384.
56. Woodage T, King SM, Wacholder S, et al. The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet. 1998;20(1):62-65.
57. Lothe RA, Hektoen M, Johnsen H, et al. The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res. 1998; 58(14):2923-2924.
58. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A. 1998;95(18):10722-10727.
59. Zauber NP, Sabbath-Solitare M, Marotta S, et al. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer. 2005;104(4):719-729.
60. Michils G, Tejpar S, Fryns JP, et al. Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD). Eur J Hum Genet. 2002;10(9): 505-510.